PLOD1
Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1
Also known as: LH1, LLH, PLOD, PLOD1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q02809
- Gene
- PLOD1
- Ensembl
- ENSG00000083444
- Chromosome
- 1
- Canonical length
- 727 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Vesicles
- Secretome location
- Intracellular and membrane
- Quaternary structure
- Homodimer
OverviewNCBI Gene
Lysyl hydroxylase is a membrane-bound homodimeric protein localized to the cisternae of the endoplasmic reticulum. The enzyme (cofactors iron and ascorbate) catalyzes the hydroxylation of lysyl residues in collagen-like peptides. The resultant hydroxylysyl groups are attachment sites for carbohydrates in collagen and thus are critical for the stability of intermolecular crosslinks. Some patients with Ehlers-Danlos syndrome type VI have deficiencies in lysyl hydroxylase activity. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2015]
Canonical amino-acid sequenceUniProt
727 residues, UniProt reviewed canonical sequence.
>Q02809|PLOD1
1 MRPLLLLALL GWLLLAEAKG DAKPEDNLLV LTVATKETEG FRRFKRSAQF FNYKIQALGL
61 GEDWNVEKGT SAGGGQKVRL LKKALEKHAD KEDLVILFAD SYDVLFASGP RELLKKFRQA
121 RSQVVFSAEE LIYPDRRLET KYPVVSDGKR FLGSGGFIGY APNLSKLVAE WEGQDSDSDQ
181 LFYTKIFLDP EKREQINITL DHRCRIFQNL DGALDEVVLK FEMGHVRARN LAYDTLPVLI
241 HGNGPTKLQL NYLGNYIPRF WTFETGCTVC DEGLRSLKGI GDEALPTVLV GVFIEQPTPF
301 VSLFFQRLLR LHYPQKHMRL FIHNHEQHHK AQVEEFLAQH GSEYQSVKLV GPEVRMANAD
361 ARNMGADLCR QDRSCTYYFS VDADVALTEP NSLRLLIQQN KNVIAPLMTR HGRLWSNFWG
421 ALSADGYYAR SEDYVDIVQG RRVGVWNVPY ISNIYLIKGS ALRGELQSSD LFHHSKLDPD
481 MAFCANIRQQ DVFMFLTNRH TLGHLLSLDS YRTTHLHNDL WEVFSNPEDW KEKYIHQNYT
541 KALAGKLVET PCPDVYWFPI FTEVACDELV EEMEHFGQWS LGNNKDNRIQ GGYENVPTID
601 IHMNQIGFER EWHKFLLEYI APMTEKLYPG YYTRAQFDLA FVVRYKPDEQ PSLMPHHDAS
661 TFTINIALNR VGVDYEGGGC RFLRYNCSIR APRKGWTLMH PGRLTHYHEG LPTTRGTRYI
721 AVSFVDPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PLOD1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.24
- Highest tissue expression
- 79 nTPM
Expression across tissuesHPA
Tissue
- placenta: 79 nTPM
- smooth muscle: 73 nTPM
- liver: 73 nTPM
- ovary: 72 nTPM
- salivary gland: 72 nTPM
- heart muscle: 67 nTPM
Single-cell type
- extravillous trophoblasts: 365 nCPM
- decidual stromal cells: 102 nCPM
- hepatic stellate cells: 90 nCPM
- myosatellite cells: 80 nCPM
- migrating cytotrophoblasts: 68 nCPM
- pericytes: 68 nCPM
Immune cell
- classical monocyte: 40 nTPM
- neutrophil: 36 nTPM
- intermediate monocyte: 34 nTPM
- myeloid DC: 33 nTPM
- non-classical monocyte: 33 nTPM
- total PBMC: 23 nTPM
Brain region
- thalamus: 54 nTPM
- pons: 54 nTPM
- white matter: 52 nTPM
- midbrain: 50 nTPM
- basal ganglia: 50 nTPM
- medulla oblongata: 47 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about PLOD1.
Disease | AllUniProt
Conditions PLOD1 is implicated in, by any mechanism.
- Ehlers-Danlos syndrome, kyphoscoliotic type, 1 (EDSKSCL1) MIM:225400
Disease | GeneticClinVar
114 pathogenic / likely-pathogenic of 1,419 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Ehlers-Danlos syndrome, kyphoscoliotic type 1
- Familial thoracic aortic aneurysm and aortic dissection
- Ehlers-Danlos syndrome
- PLOD1-related disorder
- 6 conditions
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.94
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.39
- DepMap mean gene effect
- 0.05
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- collagen biosynthetic process
- collagen fibril organization
- epidermis development
- hydroxylysine biosynthetic process
- response to hypoxia
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Procollagen-lysine 5-dioxygenase, conserved site
- Oxoglutarate/iron-dependent dioxygenase domain
- Prolyl 4-hydroxylase, alpha subunit
- Nucleotide-diphospho-sugar transferases
- Isopenicillin N synthase-like, Fe(2+) 2OG dioxygenase domain
- Collagen-modifying Glycosyltransferase 25
- PLOD1-3-like, GT domain
- 2OG-Fe(II) oxygenase superfamily
- OGFOD2-like domain
- PLOD GT domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PLOD1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PLOD1 as an antibody target. Whether an autoantibody or antibody against PLOD1 could matter depends on whether native PLOD1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PLOD1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PLOD1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...